Levofloxacin Pharmacokinetics in the Severely Obese.
Phase of Trial: Phase IV
Latest Information Update: 08 Jun 2018
At a glance
- Drugs Levofloxacin (Primary)
- Indications Bacterial infections
- Focus Pharmacokinetics
- 18 Feb 2009 Planned number of patients changed from 30 to 25 as reported by ClinicalTrials.gov.
- 18 Feb 2009 Actual end date (Jun 2008) added as reported by ClinicalTrials.gov.
- 18 Feb 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.